Home sleep apnea testing in people with atrial fibrillation
Tests whether home sleep apnea testing affects well-being in adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients With Atrial Fibrillation Using a Decentralized Platform
Key facts
- Where
- Hellerup, DenmarkSee the site
Where in Denmark
- Herlev-Gentofte HospitalHellerup, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev and Gentofte Hospital
- Trial code
- NCT06618417
- Record updated
- 26 August 2026
- Original description
The goal of this clinical trial is to find out if testing for sleep apnea (a condition where breathing stops and starts during sleep) at home can improve well-being in people with atrial fibrillation (an irregular heartbeat condition). About 936 participants will be involved. They will either be tested for sleep apnea and treated, if needed, or not tested at all.Read full original descriptionShow less
National Decentral/Virtual Randomized Trial Testing Remote Sleep Apnea Evaluation in Patients With Atrial Fibrillation
The goal of this clinical trial is to find out if testing for sleep apnea (a condition where breathing stops and starts during sleep) at home can improve well-being in people with atrial fibrillation (an irregular heartbeat condition). About 936 participants will be involved. They will either be tested for sleep apnea and treated, if needed, or not tested at all.
Researchers will compare the well-being and heart-related symptoms of participants who are tested for sleep apnea to those who are not. These will be tracked using a mobile app to monitor symptoms, physical activity, and heart rhythm.
Main hypothesis: Participants with atrial fibrillation who are tested and possibly treated for sleep apnea will have improved quality of life scores (measured by the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire) by at least 5 points after 18 weeks.
Inclusion: Established paroxysmal or persistent AF diagnosis; Owning a compatible smartphone; 18 years or older.
Exclusion: Previous investigation for sleep-disturbed breathing; Advanced heart failure (left ventricular dysfunction and NYHA III/IV); Peripheral arterial disease with daily intermittent claudication; Occupational driver licenses; Pregnancy; Doxazosin or Terazosin treatment (alpha-adrenergic antagonists).